-
RAPT Therapeutics (NASDAQ:RAPT) Receives "Hold" Rating from Stifel Nicolaus
Source: Buzz FX / 13 Nov 2024 08:16:19 America/Chicago
RAPT Therapeutics (NASDAQ:RAPT) Receives "Hold" Rating from Stifel Nicolaus Written by MarketBeat November 13, 2024 Share Link copied to clipboard. RAPT Therapeutics ( NASDAQ:RAPT - Get Free Report ) 's stock had its "hold" rating reaffirme
Read more...